Sun Pharmaceutical Industries Share Price Today - Live Blog for December 23, 2025

The share price of Sun Pharmaceutical Industries Ltd experienced a -0.05% slump and is currently trading at ₹1,754.75. While the stock maintains a PE ratio of 39.9300, the industry PE is 33.3119, raising questions about valuation.

The share price of Sun Pharmaceutical Industries Ltd has plummeted by -0.08%, signalling a challenging period. Currently trading at ₹1,754.75, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Sun Pharmaceutical Industries Ltd's shares experienced a 0.11% uptick, and they are currently valued at ₹1,757.25, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.0670 and an ROE of 14.8407%.

Sun Pharmaceutical Industries Ltd shares saw a -0.06% decrease, reaching a current market price of ₹1,755.60. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 39.9300, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

Sun Pharmaceutical Industries Ltd shares saw a -0.09% decrease, reaching a current market price of ₹1,756.60. Investors are keeping a close watch on this development, looking for potential signals of a turnaround. The stock has a PE ratio of 39.9300, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

Sun Pharmaceutical Industries Ltd witnessed a substantial 0.08% increase in its share price and is currently trading at ₹1,758.30. This remarkable performance has caught the eye of investors.

The share price of Sun Pharmaceutical Industries Ltd has plummeted by -0.06%, signalling a challenging period. Currently trading at ₹1,756.95, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Sun Pharmaceutical Industries Ltd stock price decreased by -0.01%, with the current market value at ₹1,758.50 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The stock of Sun Pharmaceutical Industries Ltd is on the rise, registering an impressive 0.02% increase and currently trading at ₹1,758.65 per share. Investors are taking notice of this upward momentum.

Sun Pharmaceutical Industries Ltd stock price decreased by -0.23%, with the current market value at ₹1,757.60 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Increased investor interest has propelled Sun Pharmaceutical Industries Ltd's stock to a significant 0.04% gain, with the share price now at ₹1,761.60. Notably, the stock's PE ratio stands at 39.9300, and its Return on Equity (ROE) is 14.8407%.

Sun Pharmaceutical Industries Ltd experienced a -0.24% downturn in its share price, and it's currently trading at ₹1,761.15. This situation is generating interest among value investors who are evaluating the stock's potential.

The share price of Sun Pharmaceutical Industries Ltd experienced an impressive 0.06% upswing and is currently trading at ₹1,765.20, indicating strong market sentiment.

Sun Pharmaceutical Industries Ltd observed a -0.17% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,764.65. The stock has a PE ratio of 39.9300, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

The stock of Sun Pharmaceutical Industries Ltd is on the rise, registering an impressive 0.11% increase and currently trading at ₹1,767.60 per share. Investors are taking notice of this upward momentum.

The share price of Sun Pharmaceutical Industries Ltd experienced a -0.12% slump and is currently trading at ₹1,765.00. While the stock maintains a PE ratio of 39.9300, the industry PE is 33.3119, raising questions about valuation.

Sun Pharmaceutical Industries Ltd's share price has fallen by -0.06%, a situation worth noting. At present, the stock is trading at ₹1,766.90. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 39.9300, while the industry PE ratio is 33.3119.

Sun Pharmaceutical Industries Ltd witnessed a -0.07% decrease in its share price, and it is currently trading at ₹1,768.50. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 39.9300, an ROE of 14.8407% and a debt to equity ratio of 0.0670.

Sun Pharmaceutical Industries Ltd witnessed a -0.11% drop in its share price and is currently trading at ₹1,769.30. With the stock's PE at 39.9300 and the industry PE at 33.3119, investors are weighing their options.

Following a noteworthy 0.05% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,770.00. When it comes to valuation, this stock has a PE ratio of 39.9300, with the industry PE ratio at 33.3119.

With a -0.12% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,767.80. The stock is currently trading at a PE of 39.9300, while the industry PE is 33.3119, prompting investors to assess its value proposition.

After a notable 0.00% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,768.45. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.0670 and an ROE of 14.8407%.

The share price of Sun Pharmaceutical Industries Ltd experienced an impressive 0.05% upswing and is currently trading at ₹1,768.80, indicating strong market sentiment.

Sun Pharmaceutical Industries Ltd witnessed a notable 0.11% surge in its share price and is presently trading at ₹1,770.00, captivating the attention of market participants.

Sun Pharmaceutical Industries Ltd has had quite the run lately, experiencing a substantial 0.31% uptick in its share price. As a result, it's now actively trading at ₹1,768.05 per share, making it an attractive option for investors.

Sun Pharmaceutical Industries Ltd experienced a -0.71% dip in its share price and is currently trading at ₹1,763.70. The stock has a PE ratio of 39.9300, an ROE of 14.8407% and a debt to equity ratio of 0.0670.